Research-based Biopharmaceutical Company Grants DATATRAK With Two New Studies

DATATRAK has signed two new studies with a global research-based biopharmaceutical company, which includes a multi-site, five-year study. The company said that the contract demonstrates a long-term commitment to the DATATRAK eClinical platform.

DATATRAK claims, eClinical empowers clinical users and service providers with the tools necessary for efficiently conducting, delivering and managing clinical trials. Built upon a unified architecture, eClinical’s Clinical Suite, Trial Manager, Enterprise Manager and Enterprise Platform components provide the foundation for Clinical Trial Solutions.

Laurence Birch, chairman of DATATRAK, said: We are pleased that our partnership with this biopharmaceutical continues to grow. The signing of new business with existing clients validates our technology and service delivery model, DATATRAK ONE. Our Enterprise Transfer clients are able to successfully develop and deliver trials utilizing DATATRAK’s technology and online resources.